The store will not work correctly when cookies are disabled.
US8889672, 317-010-004
ID: ALA3702546
PubChem CID: 61309903
Max Phase: Preclinical
Molecular Formula: C15H15NO4S
Molecular Weight: 305.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)OC(=O)c1c(-c2ccc3c(c2)OCO3)csc1N
Standard InChI: InChI=1S/C15H15NO4S/c1-8(2)20-15(17)13-10(6-21-14(13)16)9-3-4-11-12(5-9)19-7-18-11/h3-6,8H,7,16H2,1-2H3
Standard InChI Key: JFYGZNMEZXPYFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
2.5299 3.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4277 3.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5660 3.4326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1277 1.5822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2506 0.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3890 0.9663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9511 -0.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9531 -1.9978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1467 -1.8743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2010 -3.2956 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.7343 -2.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 1.2135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6065 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 -1.2135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
5 7 1 0
7 8 2 0
8 9 1 0
8 10 1 0
10 11 1 0
11 12 2 0
12 7 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
20 21 2 0
21 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.36 | Molecular Weight (Monoisotopic): 305.0722 | AlogP: 3.29 | #Rotatable Bonds: 3 |
Polar Surface Area: 70.78 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.88 | Np Likeness Score: -0.69 |
References
1. (2014) Compounds, formulations, and methods of protein kinase C inhibition, |